Specific inhibition of in vitro Candida-induced lymphocyte proliferation by polysaccharidic antigens present in the serum of patients with chronic mucocutaneous candidiasis.
about
An immune defect causing dominant chronic mucocutaneous candidiasis and thyroid disease maps to chromosome 2p in a single family.Measurement of T-cell-derived antigen binding molecules and immunoglobulin G specific to Candida albicans mannan in sera of patients with recurrent vulvovaginal candidiasis.Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis.Abrogation of suppression of delayed hypersensitivity induced by Candida albicans-derived mannan by treatment with monophosphoryl lipid A.Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasisCharacterization of CD8+ T cells and microenvironment in oral lesions of human immunodeficiency virus-infected persons with oropharyngeal candidiasis.Immunopathogenesis of recurrent vulvovaginal candidiasis.Immunohistochemical evaluation of T cells in oral lesions from human immunodeficiency virus-positive persons with oropharyngeal candidiasis.Mannan as an antigen in cell-mediated immunity (CMI) assays and as a modulator of mannan-specific CMI.Mice immunized by primary vaginal Candida albicans infection develop acquired vaginal mucosal immunity.Antibody immunity and invasive fungal infectionsCutaneous defenses against dermatophytes and yeasts.Use of cellular depletion analysis to examine circulation of immune effector function between the vagina and the peripheryEffects of preinduced Candida-specific systemic cell-mediated immunity on experimental vaginal candidiasis.Serum regulation of in vitro lymphocyte responses in early experimental syphilis.Purification and characterization of a mannose-containing disaccharide obtained from human pregnancy urine. A new immunoregulatory saccharide.Influence of yeast mannan on human neutrophil functions: inhibition of release of myeloperoxidase related to carbohydrate-binding property of the enzyme.Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis.Candida mannan: chemistry, suppression of cell-mediated immunity, and possible mechanisms of action.Suppression of lymphocyte responses by tuberculous plasma and mycobacterial arabinogalactan. Monocyte dependence and indomethacin reversibilityProduction and function of cytokines in natural and acquired immunity to Candida albicans infection.Expression of the C3d-binding protein (CR2) from Candida albicans during experimental candidiasis as measured by lymphoblastogenesis.Characterization of Candida albicans mannan-induced, mannan-specific delayed hypersensitivity suppressor cells.Specific in vitro antimannan-rich antigen of Candida albicans antibody production by sensitized human blood lymphocytes.Immunoregulation in experimental murine candidiasis: specific suppression induced by Candida albicans cell wall glycoproteinInduction of natural killer cell activity by inactivated Candida albicans in miceTwo mechanisms of inhibition of human lymphocyte proliferation by soluble yeast mannan polysaccharideCandidacidal activity of myeloperoxidase: mechanisms of inhibitory influence of soluble cell wall mannan.Detection of Candida antigen in sera of patients with candidiasis by an enzyme-linked immunosorbent assay-inhibition technique.Mannose in body fluids as an indicator of invasive candidiasis.Antigens and immune responses in Candida albicans infection.Candida cell wall mannan: a polysaccharide with diverse immunologic properties.Parasitic adaptation of pathogenic fungi to mammalian hosts.Deregulated production of protective cytokines in response to Candida albicans infection in patients with chronic mucocutaneous candidiasis.Production of a suppressor factor by CD8+ lymphocytes activated by mycobacterial components.Monoclonal antibodies against Candida tropicalis mannan: antigen detection by enzyme immunoassay and immunofluorescence.
P2860
Q24533389-602FF97D-D5F6-40B0-BFD6-6734A63D0653Q33595842-8FD95C0A-67F9-4170-ACDA-874C16D67022Q33596378-70614AEB-2930-463E-AA4B-1F31FF9F8D53Q33597356-3F374907-6BF3-4375-A9EF-A4796AC5E88FQ33610699-A0B5BE8A-A059-4BEF-ABEA-89C119C2BF55Q33788275-9C372562-DA1D-476E-9213-B18943506534Q34397458-017C66FC-161E-459C-9BB9-2B8010D0B7FEQ34581894-CA4FEADD-FB7F-4BFF-95B4-29BA953BFD77Q35091954-112010C4-5800-4905-BDAD-D97E551FF843Q35385497-7CFB981F-525F-4489-99B8-FC0283F596BEQ35447692-CD505950-AE98-4526-8883-00AF6B114445Q35535018-423BCC33-9270-4613-9B50-235236506202Q35555927-80038239-18C8-4F55-A19C-EA36C0A298F5Q35775332-DE096AC3-6793-492B-9978-7336EEA370F1Q36331087-D76A2729-C173-4DF6-B835-B5AD44362C63Q36349685-54D354DD-8BC0-433B-AC50-D4C499062D87Q36447573-3B9FB300-C4BF-4F95-96AF-DDCE3E8A7CF1Q36512728-73CBE519-A3FC-4242-B31B-9118A7260EFCQ36636840-B16E9F7F-D569-48F7-94AC-8A658010D0E7Q36639902-5E44C0E9-3A4F-452F-9173-ED9F53F22AE7Q36670422-6F93C6D2-730B-496A-9C73-D8C549B7FE4AQ36953380-76B47EA5-EA59-4C18-8B12-4485A138F41DQ36987055-43EE06F4-456A-43C4-B43E-002B41AD7A70Q36989657-E188C7FC-4681-4A6D-BCA4-4707050A89F8Q37051200-53C6BB01-1B1F-442E-A882-6385727AEF7AQ37053352-CC601ED8-EAC0-4790-A3FD-8454F883650AQ37097651-2E223297-7D60-4BB2-BEA3-7E364481FADFQ37103560-3DDF4E38-9074-442E-B7C5-988F93D84088Q37316364-FF10E76C-3374-4D26-AFBE-D628A4E7B80EQ37337811-B36BD1E8-62BD-4D5A-B90E-BDD9384E142DQ37909862-57F9F91B-E47B-4EC1-85E9-CC5E9CE5B1D8Q38677401-76B9FF99-5BE8-43B2-8D45-889D3E27FE08Q39745386-71E1E88D-B59D-4DBB-BC24-3485E32655BCQ39913037-38AB0842-EDF9-4123-BF0F-C88AD44C304EQ40151456-958E6C96-5D58-47CA-BD22-FC9B97FFF542Q40207346-F02304D7-9F1A-4226-BDC9-022BA27EC359
P2860
Specific inhibition of in vitro Candida-induced lymphocyte proliferation by polysaccharidic antigens present in the serum of patients with chronic mucocutaneous candidiasis.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年学术文章
@wuu
1978年学术文章
@zh-cn
1978年学术文章
@zh-hans
1978年学术文章
@zh-my
1978年学术文章
@zh-sg
1978年學術文章
@yue
1978年學術文章
@zh
1978年學術文章
@zh-hant
name
Specific inhibition of in vitr ...... nic mucocutaneous candidiasis.
@en
Specific inhibition of in vitr ...... nic mucocutaneous candidiasis.
@nl
type
label
Specific inhibition of in vitr ...... nic mucocutaneous candidiasis.
@en
Specific inhibition of in vitr ...... nic mucocutaneous candidiasis.
@nl
prefLabel
Specific inhibition of in vitr ...... nic mucocutaneous candidiasis.
@en
Specific inhibition of in vitr ...... nic mucocutaneous candidiasis.
@nl
P2093
P2860
P356
P1476
Specific inhibition of in vitr ...... nic mucocutaneous candidiasis.
@en
P2093
P2860
P304
P356
10.1172/JCI109204
P407
P577
1978-11-01T00:00:00Z